Enhanced Techniques of NMIBC Detection
Dr. Mark D. Tyson, II, MD, MPH, moderates this session by discussing the critical need for precise detection techniques in managing NMIBC.
Read More
Mark Tyson II, MD, MPH
Mayo Clinic
Phoenix, Arizona
Mark D. Tyson II, MD, MPH, is the Vice Chair for Research and a Professor in the Department of Urology with the Mayo Clinic in Phoenix, Arizona. Dr. Tyson also serves as the Vice Chair of the Surgical and Procedural Committee and the Chair of the Surgical Quality Subcommittee at the Mayo Clinic. His clinical focus includes treatments for bladder cancer, including single port radical cystectomy with urinary diversion. Dr. Tyson’s research interests include the treatment of non-muscle and muscle-invasive bladder cancer, and he specializes in clinical trials related to BCG-unresponsive bladder cancer.
Dr. Tyson earned his medical degree at Dartmouth Medical School in Lebanon, New Hampshire. He completed residencies in Urology and Surgery at the Mayo Clinic in Phoenix, Arizona. Dr. Tyson then completed a fellowship in Urologic Oncology from Vanderbilt University in Nashville, Tennessee. He earned a Master's in Public Health, with an emphasis in Epidemiology and Biostatistics, from Harvard in Cambridge, Massachusetts.
Dr. Tyson also serves as a board member of the Mayo Clinic Institutional Review Board. He has published 126 articles and serves as an assistant editor for The Journal of Urology. Dr. Tyson's research significantly advances patient care in the field of urology. This is particularly true for patients undergoing bladder removal surgery and being treated for NMIBC. Dr. Tyson's leadership in clinical trials introduces new treatments for BCG-naive and BCG-unresponsive NMIBC. This work addresses critical unmet needs in bladder cancer treatment. Also, his comparative studies on urine-based molecular testing versus cystoscopy aim to refine NMIBC monitoring to make sure patients are as comfortable and satisfied as possible while maintaining strict monitoring standards.
Talks by Mark Tyson II, MD, MPH